These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8142882)

  • 1. In vitro anti-human cytomegalovirus activity of liposome-encapsulated foscarnet.
    Gümbel HO; Rückert DG; Cinatl J; Rabenau H; Doerr HW; Ohrloff C
    Ger J Ophthalmol; 1994 Jan; 3(1):5-8. PubMed ID: 8142882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased efficacy of ganciclovir and foscarnet inhibition of cytomegalovirus replication in vitro by encapsulation in liposomes.
    Bakker-Woudenberg IA; Lokerse AF; ten Kate M
    Scand J Infect Dis Suppl; 1990; 74():54-7. PubMed ID: 1965866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is combination antiviral therapy for CMV superior to monotherapy?
    Drew WL
    J Clin Virol; 2006 Apr; 35(4):485-8. PubMed ID: 16387546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro susceptibility to ganciclovir and foscarnet of cytomegaloviruses].
    Otegui M; Rabella N; Labeaga R; Herrero M; Margall R; Muñoz JM; Prats G
    Rev Esp Quimioter; 2001 Jun; 14(2):155-64. PubMed ID: 11704769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal toxicology and duration of efficacy of a novel antiviral lipid prodrug of ganciclovir in liposome formulation.
    Cheng L; Hostetler KY; Chaidhawangul S; Gardner MF; Beadle JR; Keefe KS; Bergeron-Lynn G; Severson GM; Soules KA; Mueller AJ; Freeman WR
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1523-32. PubMed ID: 10798672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal toxicology in rabbits of two preparations of 1-O-octadecyl-sn-glycerol-3-phosphonoformate, a sustained-delivery anti-CMV drug.
    Cheng L; Hostetler KY; Gardner MF; Avila CP; Bergeron-Lynn G; Keefe KS; Wiley CA; Freeman WR
    Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1487-95. PubMed ID: 10359331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mutation in the UL54 gene of human cytomegalovirus isolates that confers resistance to foscarnet.
    Ducancelle A; Champier G; Alain S; Petit F; Le Pors MJ; Mazeron MC
    Antivir Ther; 2006; 11(4):537-40. PubMed ID: 16856628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth phenotypes of cytomegalovirus isolates do not correlate with glycoprotein B, major immediate early genotypes or antiviral sensitivity.
    Mousavi-Jazi M; Sundqvist VA; Linde A; Wahren B; Brytting M
    J Med Virol; 2000 Oct; 62(2):117-26. PubMed ID: 11002239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations conferring foscarnet resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis.
    Weinberg A; Jabs DA; Chou S; Martin BK; Lurain NS; Forman MS; Crumpacker C; ;
    J Infect Dis; 2003 Mar; 187(5):777-84. PubMed ID: 12599051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and antiviral activity of alpha-nucleosides: D- and L-isomers of lyxofuranosyl- and (5-deoxylyxofuranosyl)benzimidazoles.
    Migawa MT; Girardet JL; Walker JA; Koszalka GW; Chamberlain SD; Drach JC; Townsend LB
    J Med Chem; 1998 Apr; 41(8):1242-51. PubMed ID: 9575044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a non-radioactive DNA polymerase assay for studying cytomegalovirus resistance to foscarnet.
    Ducancelle A; Alain S; Petit F; Sanson Le Pors MJ; Mazeron MC
    J Virol Methods; 2007 May; 141(2):212-5. PubMed ID: 17197042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A novel colorimetric test to study the susceptibility of human cytomegalovirus DNA polymerase to foscarnet].
    Ducancelle A; Alain S; Scieux C; Fillet AM; Petit F; Sanson-Le Pors MJ; Mazeron MC
    Pathol Biol (Paris); 2005; 53(8-9):551-5. PubMed ID: 16084026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of human cytomegalovirus to two-drug combinations in vitro.
    Manion DJ; Vibhagool A; Chou TC; Kaplan J; Caliendo A; Hirsch MS
    Antivir Ther; 1996 Dec; 1(4):237-45. PubMed ID: 11324826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid determination of antiviral drug susceptibility of human cytomegalovirus by real-time PCR.
    Schnepf N; Boiteau N; Petit F; Alain S; Sanson-Le Pors MJ; Mazeron MC
    Antiviral Res; 2009 Jan; 81(1):64-7. PubMed ID: 18992772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination and pharmacokinetic profile of liposomal foscarnet in rabbit ocular tissues after intravitreal administration.
    Claro C; Ruiz R; Cordero E; Pastor MT; López-Cortés LF; Jiménez-Castellanos M; Lucero M
    Exp Eye Res; 2009 Mar; 88(3):528-34. PubMed ID: 19084004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic characterisation of cytomegalovirus DNA polymerase: a method to study cytomegalovirus isolates resistant to foscarnet.
    Ducancelle A; Gravisse J; Alain S; Fillet AM; Petit F; Pors MJ; Mazeron MC
    J Virol Methods; 2005 May; 125(2):145-51. PubMed ID: 15794984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir.
    Jabs DA
    Infect Agents Dis; 1995 Sep; 4(3):131-42. PubMed ID: 8548191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and in vitro activities of a new antiviral duplex drug linking Zidovudine (AZT) and Foscarnet (PFA) via an octadecylglycerol residue.
    Schott H; Hamprecht K; Schott S; Schott TC; Schwendener RA
    Bioorg Med Chem; 2009 Jan; 17(1):303-10. PubMed ID: 19010684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II, double-masked, randomized, placebo-controlled evaluation of a human monoclonal anti-Cytomegalovirus antibody (MSL-109) in combination with standard therapy versus standard therapy alone in the treatment of AIDS patients with Cytomegalovirus retinitis.
    Borucki MJ; Spritzler J; Asmuth DM; Gnann J; Hirsch MS; Nokta M; Aweeka F; Nadler PI; Sattler F; Alston B; Nevin TT; Owens S; Waterman K; Hubbard L; Caliendo A; Pollard RB;
    Antiviral Res; 2004 Nov; 64(2):103-11. PubMed ID: 15498605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraocular therapy for cytomegalovirus retinitis.
    Palestine AG
    J Int Assoc Physicians AIDS Care; 1996 May; 2(5):25-8. PubMed ID: 11363527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.